Stock listing
NASDAQ:TRAW Traws Pharma, Inc. Stock
Home listing (NASDAQ) of Traws Pharma, Inc.
Follow Traws Pharma, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:TRAW
$0.30 USD +0.00 (+1.5%)
Close on Nov 2, 2026
- Day range
- $0.298 – $0.31 USDNov 2, 2026
- Volume
- 70,063 sharesNov 2, 2026
- Market cap
- $4.62M USDAt the close on Nov 2, 2026 · price × 15.37M shares outstanding
- 52-week range
- $0.288 – $3.23 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $313,350 USDMedian day 93,884 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:TRAW · Home | $0.30 USD | +0.004 (+1.5%) | 70,063 | $0.31 | $0.31 | $0.298 | $0.296 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:TRAW · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.30 | +0.004 | +1.5% | $0.31 | $0.31 | $0.298 | 70,063 | |
| $0.296 | -0.005 | -1.7% | $0.31 | $0.31 | $0.288 | 198,706 | |
| $0.301 | -0.059 | -16.3% | $0.37 | $0.37 | $0.30 | 693,333 | |
| $0.36 | -0.006 | -1.7% | $0.363 | $0.363 | $0.32 | 27,919 | |
| $0.366 | +0.025 | +7.3% | $0.341 | $0.366 | $0.31 | 150,582 | |
| $0.341 | -0.001 | -0.4% | $0.367 | $0.368 | $0.332 | 37,513 | |
| $0.343 | -0.024 | -6.6% | $0.351 | $0.351 | $0.331 | 110,673 | |
| $0.367 | -0.009 | -2.5% | $0.372 | $0.385 | $0.362 | 62,215 | |
| $0.376 | -0.001 | -0.2% | $0.385 | $0.387 | $0.368 | 84,464 | |
| $0.377 | +0.01 | +2.8% | $0.385 | $0.385 | $0.367 | 93,128 | |
| $0.367 | -0.003 | -0.8% | $0.389 | $0.389 | $0.36 | 98,996 | |
| $0.369 | -0.034 | -8.4% | $0.414 | $0.414 | $0.362 | 257,685 | |
| $0.403 | +0.002 | +0.5% | $0.40 | $0.414 | $0.391 | 45,949 | |
| $0.401 | -0.009 | -2.2% | $0.41 | $0.418 | $0.392 | 150,372 | |
| $0.41 | -0.006 | -1.4% | $0.422 | $0.43 | $0.407 | 93,884 | |
| $0.416 | -0.029 | -6.6% | $0.43 | $0.444 | $0.41 | 178,372 | |
| $0.445 | -0.035 | -7.3% | $0.467 | $0.473 | $0.434 | 689,932 | |
| $0.48 | +0.001 | +0.3% | $0.479 | $0.482 | $0.462 | 199,714 | |
| $0.479 | -0.041 | -7.9% | $0.52 | $0.52 | $0.461 | 221,835 | |
| $0.52 | -0.016 | -3.0% | $0.535 | $0.535 | $0.518 | 125,054 | |
| $0.536 | -0.032 | -5.7% | $0.556 | $0.579 | $0.53 | 161,494 | |
| $0.569 | +0.023 | +4.3% | $0.56 | $0.57 | $0.55 | 69,631 | |
| $0.545 | -0.048 | -8.2% | $0.60 | $0.60 | $0.537 | 140,678 | |
| $0.594 | -0.032 | -5.1% | $0.63 | $0.685 | $0.59 | 332,224 | |
| $0.626 | +0.047 | +8.1% | $0.562 | $0.63 | $0.542 | 391,862 | |
| $0.579 | +0.016 | +2.8% | $0.529 | $0.59 | $0.529 | 175,566 | |
| $0.563 | +0.003 | +0.6% | $0.526 | $0.57 | $0.512 | 885,763 | |
| $0.56 | +0.056 | +11.2% | $0.51 | $0.699 | $0.497 | 28,307,537 | |
| $0.504 | +0.004 | +0.7% | $0.491 | $0.504 | $0.483 | 41,428 | |
| $0.50 | +0.00 | 0.0% | $0.492 | $0.518 | $0.49 | 109,133 | |
| $0.50 | +0.01 | +2.0% | $0.49 | $0.519 | $0.48 | 128,195 | |
| $0.49 | -0.045 | -8.5% | $0.542 | $0.55 | $0.482 | 193,789 | |
| $0.536 | +0.002 | +0.4% | $0.533 | $0.55 | $0.523 | 79,644 | |
| $0.533 | +0.004 | +0.8% | $0.529 | $0.542 | $0.516 | 42,362 | |
| $0.529 | +0.01 | +1.9% | $0.523 | $0.547 | $0.516 | 33,562 | |
| $0.519 | -0.045 | -8.0% | $0.579 | $0.594 | $0.516 | 155,695 | |
| $0.564 | +0.033 | +6.2% | $0.53 | $0.59 | $0.523 | 84,469 | |
| $0.532 | -0.009 | -1.6% | $0.54 | $0.545 | $0.53 | 39,026 | |
| $0.54 | -0.012 | -2.3% | $0.55 | $0.564 | $0.537 | 179,140 | |
| $0.553 | +0.002 | +0.4% | $0.56 | $0.59 | $0.551 | 50,107 | |
| $0.55 | +0.008 | +1.5% | $0.571 | $0.571 | $0.54 | 67,291 | |
| $0.542 | -0.028 | -4.9% | $0.57 | $0.586 | $0.541 | 56,613 | |
| $0.57 | -0.02 | -3.4% | $0.607 | $0.607 | $0.57 | 28,223 | |
| $0.59 | -0.002 | -0.3% | $0.61 | $0.61 | $0.58 | 27,040 | |
| $0.592 | +0.002 | +0.4% | $0.61 | $0.61 | $0.574 | 53,488 | |
| $0.59 | +0.004 | +0.8% | $0.60 | $0.60 | $0.58 | 43,977 | |
| $0.585 | -0.016 | -2.6% | $0.61 | $0.61 | $0.58 | 63,877 | |
| $0.601 | +0.022 | +3.8% | $0.586 | $0.625 | $0.58 | 180,915 | |
| $0.579 | +0.019 | +3.4% | $0.577 | $0.58 | $0.559 | 55,573 | |
| $0.56 | +0.03 | +5.7% | $0.555 | $0.565 | $0.53 | 76,500 | |
| $0.53 | +0.01 | +1.9% | $0.52 | $0.544 | $0.52 | 219,733 | |
| $0.52 | -0.02 | -3.7% | $0.54 | $0.54 | $0.51 | 196,253 | |
| $0.54 | 0.00 | 0.0% | $0.55 | $0.555 | $0.54 | 96,317 | |
| $0.54 | 0.00 | 0.0% | $0.54 | $0.564 | $0.54 | 71,911 | |
| $0.54 | -0.031 | -5.4% | $0.56 | $0.56 | $0.534 | 104,626 | |
| $0.571 | -0.029 | -4.8% | $0.607 | $0.617 | $0.57 | 76,305 | |
| $0.60 | +0.067 | +12.5% | $0.55 | $0.615 | $0.55 | 200,154 | |
| $0.533 | -0.008 | -1.5% | $0.532 | $0.56 | $0.53 | 30,503 | |
| $0.541 | +0.001 | +0.2% | $0.54 | $0.56 | $0.54 | 38,710 | |
| $0.54 | +0.008 | +1.5% | $0.548 | $0.55 | $0.532 | 36,831 | |
| $0.532 | -0.007 | -1.3% | $0.538 | $0.55 | $0.531 | 65,676 | |
| $0.539 | -0.015 | -2.7% | $0.558 | $0.558 | $0.538 | 52,296 | |
| $0.554 | +0.001 | +0.1% | $0.569 | $0.57 | $0.53 | 70,031 | |
| $0.553 | +0.082 | +17.3% | $0.489 | $0.586 | $0.482 | 313,745 | |
| $0.472 | +0.022 | +4.8% | $0.47 | $0.487 | $0.45 | 98,592 |
- Ticker
- NASDAQ:TRAW
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Aug 14, 2026
Traws Pharma Reports Q2 2026 Financial Results and Provides Business Highlights
Latest earnings call · Apr 15, 2026
Traws Pharma (NASDAQ:TRAW) Q4 2025 Earnings Call
Replay and transcript
Latest deck · Nov 13, 2025
Investor Presentation (November 2025)
Investor deck · 46 slides
Calls
Replays
Traws Pharma (NASDAQ:TRAW) Q4 2025 Earnings Call
Wed, Apr 15, 2026 · 4:30 PM ET
Watch TranscriptTraws Pharma (NASDAQ:TRAW) Q2 2025 Earnings Call
Thu, Aug 14, 2025 · 8:30 AM ET
Watch Transcript
Latest news
Traws Pharma Reports Q2 2026 Financial Results and Provides Business Highlights
Aug 14, 2026
Closed $0.54 (-5.4%) on Aug 17, 2026
Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program
Jun 22, 2026
Closed $0.892 (+4.9%) on Jun 22, 2026
Traws Pharma Provides Regulatory Update on Influenza Program
Jun 12, 2026
Closed $0.756 (-41.0%) on Jun 15, 2026
Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks
May 27, 2026
Closed $1.53 (-3.2%) on May 27, 2026
Traws Pharma Provides Business Highlights and Reports Q1 2026 Financial Results
May 15, 2026
Closed $1.88 (+15.3%) on May 15, 2026
Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus Infections
May 8, 2026
Closed $2.18 (+28.2%) on May 8, 2026
Traws Pharma Announces Up to $60 Million Private Placement Financing
Apr 15, 2026
Closed $1.23 (-22.6%) on Apr 15, 2026
Traws Pharma Completes Analysis of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients and Provides Updates for Additional Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza
Feb 19, 2026
Closed $1.57 (-20.3%) on Feb 19, 2026
Decks
Investor Presentation (November 2025)
Investor deck · 46 slides · Nov 13, 2025
Investor Presentation (November 2025)
Investor deck · 46 slides · November 2025
Investor Presentation (August 2025)
Investor deck · 47 slides · Aug 14, 2025
Q2 2025 Earnings Presentation
Earnings · 47 slides · Aug 14, 2025
Traws Pharma, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 12 in the last 12 months · 72 in all · newest Aug 14, 2026 · oldest 2022
- Calls
- 2 calls with a replay · 2 with a transcript · latest Apr 15, 2026
- Decks
- 14 decks · latest Nov 13, 2025
Where Traws Pharma, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:TRAW · Home listing · This page | NASDAQ | United States | USD |
| BOATS:TRAW | BOATS | United States | USD |
| gettex:0T20 | gettex | Germany | EUR |
| Munich:0T20 | Munich | Germany | EUR |
| Frankfurt:0T20 | Frankfurt | Germany | EUR |
| Lang & Schwarz:A40PJ7 | Lang & Schwarz | Germany | EUR |
Log in to ask 6ix AI your own questions about Traws Pharma, Inc.